Yahata Takashi, Yumino Shizu, Seng Yin, Miyatake Hiroko, Uno Tomoko, Muguruma Yukari, Ito Mamoru, Miyoshi Hiroyuki, Kato Shunichi, Hotta Tomomitsu, Ando Kiyoshi
Division of Hematopoiesis, Research Center for Regenerative Medicine, Tokai University School of Medicine, Isehara, Kanagawa.
Blood. 2006 Oct 1;108(7):2446-54. doi: 10.1182/blood-2006-02-002204. Epub 2006 Jun 6.
To elucidate the in vivo kinetics of human hematopoietic stem cells (HSCs), CD34+CD38- cells were infected with lentivirus vector and transplanted into immunodeficient mice. We analyzed the multilineage differentiation and self-renewal abilities of individual thymus-repopulating clones in primary recipients, and their descending clones in paired secondary recipients, by tracing lentivirus gene integration sites in each lymphomyeloid progeny using a linear amplification-mediated polymerase chain reaction (PCR) strategy. Our clonal analysis revealed that a single human thymus-repopulating cell had the ability to produce lymphoid and myeloid lineage cells in the primary recipient and each secondary recipient, indicating that individual human HSCs expand clonally by self-renewal division. Furthermore, we found that the proportion of HSC clones present in the CD34+ cell population decreased as HSCs replicated during extensive repopulation and also as the differentiation capacity of the HSC clones became limited. This indicates the restriction of the ability of individual HSCs despite the expansion of total HSC population. We also demonstrated that the extensive self-renewal potential was confined in the relatively small proportion of HSC clones. We conclude that our clonal tracking studies clearly demonstrated that heterogeneity in the self-renewal capacity of HSC clones underlies the differences in clonal longevity in the CD34+ stem cell pool.
为阐明人类造血干细胞(HSC)的体内动力学,将慢病毒载体感染CD34+CD38-细胞并移植到免疫缺陷小鼠体内。我们通过使用线性扩增介导的聚合酶链反应(PCR)策略追踪每个淋巴细胞和髓细胞后代中的慢病毒基因整合位点,分析了原代受体中单个胸腺重建克隆及其配对的二代受体中其衍生克隆的多谱系分化和自我更新能力。我们的克隆分析表明,单个人类胸腺重建细胞能够在原代受体和每个二代受体中产生淋巴细胞和髓细胞谱系细胞,这表明单个人类造血干细胞通过自我更新分裂进行克隆性扩增。此外,我们发现,在广泛的细胞重建过程中,随着造血干细胞的复制以及造血干细胞克隆的分化能力受到限制,CD34+细胞群体中存在的造血干细胞克隆比例下降。这表明尽管造血干细胞总数有所增加,但单个造血干细胞的能力受到了限制。我们还证明,广泛的自我更新潜力局限于相对较小比例的造血干细胞克隆中。我们得出结论,我们的克隆追踪研究清楚地表明,造血干细胞克隆自我更新能力的异质性是CD34+干细胞池中克隆寿命差异的基础。